X-Therma CTO Dr. Mark Kline will give an insightful presentation at University of California, Berkeley (UCB) Stem Cell Retreat

X-Therma CTO Dr. Mark Kline will give an insightful presentation at University of California, Berkeley (UCB) Stem Cell Retreat in Monterey, CA where the frontier stem cell research of UC-Berkeley and others is revealed annually. We are here to help scientists with better solutions to preserve the precious stem cells and engineered organs.

The Second China Shenzhen Innovation and Entrepreneurship International Competition

X-Therma was awarded 3rd place (241 teams in Silicon Valley, 1400 teams globally) of “The 2nd China Shenzhen Innovation and Entrepreneurship International Competition”, Silicon Valley division and brought home a prize of RMB 30,000. Congratulations to the Team!

Confidence with XT-ViVoTM

X-Therma CEO Dr. Xiaoxi Wei welcomed her first baby into the world and is proud he became the first donor and “Patient” for X-Therma CORDX program. The medical team at Kaiser Permanente Oakland Medical Center collected the cord blood, cord tissue and placenta from the newborn with X-Therma’s collection kit. The precious cord and placental […]

X-Therma is Invited to Present at ACS Entreprenur Summit

Dr. Mark Kline, Chief Technology Officer of X-Therma will deliver an enchanting entreprenuer story at the American Chemical Society (ACS) Entreprenuer Summit on Nov 15-16th, Washington D.C.   https://www.acs.org/content/acs/en/meetings/acs-entrepreneur-summit.html

X-Therma CEO Dr. Xiaoxi Wei is invited to give a plenary talk and a presentation at the CRYO this July in China

X-Therma CEO Dr. Xiaoxi Wei is invited to give a plenary talk and a section presentation on our new generation of cryoprotectants for the regenerative medicine industry at the CRYO17 Meeting in Hefei, China  

X-Therma is selected by the California Institute of Regenerative Medicine (CIRM) for highly competitive funding

X-Therma is selected by the California Institute of Regenerative Medicine (CIRM) for highly competitive funding to fuel X-Therma’s development to advance critical stem cell manufacturing processes.  

X-Therma is competitively selected for a third US Department of the Army SBIR Phase II SBIR contract

X-Therma is competitively selected for a third US Department of the Army SBIR Phase II SBIR contract. X-Therma’s CryomatrixTM is a new pipeline of non-toxic and hyper-effective cryoprotectants in development for cell, tissue, and organ banking.  

X-Therma CEO Dr. Xiaoxi Wei’s career development story is featured in Chemical &Engineering News

X-Therma CEO Dr. Xiaoxi Wei’s career development story is featured in Chemical &Engineering News (C&EN, Volume 95 Issue 23 | p. 23| Issue Date: June 5, 2017). An enlightening story of her inspiration to start the startup journey guided by a childhood dream. http://cen.acs.org/articles/95/i23/Career-Ladder-Xiaoxi-Wei.html  

X-Therma is competitively selected for a second US Department of Defense Phase II SBIR contract

X-Therma is competitively selected for a second US Department of Defense Phase II SBIR contract. This contract funds genitourinary organ transplants performed with XT-ViVoTM  cryopreserved tissue.  

X-Therma CEO Dr. Xiaoxi Wei was an invited speaker to give an inspirational talk at Women chemists Committee (WCC)

X-Therma CEO Dr. Xiaoxi Wei was an invited speaker to give an inspirational talk at Women chemists Committee (WCC) on entrepreneurship at the WCC in Chemical Enterprise Breakfast for the American Chemical Society, the world’s largest scientific society.